Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0263USD
−26.57 MUSD
1.13 B
About IMMUTEP LIMITED
Sector
Industry
CEO
Marc Voigt
Website
Headquarters
Sydney
Founded
1987
ISIN
AU000000IMM6
FIGI
BBG000PP3084
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987, and is headquartered in Sydney, Australia.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PRRUF is 0.1831 USD — it has decreased by 30.67% in the past 24 hours. Watch Immutep Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Immutep Ltd. stocks are traded under the ticker PRRUF.
PRRUF stock has fallen by 35.52% compared to the previous week, the month change is a 35.52% fall, over the last year Immutep Ltd. has showed a 15.82% decrease.
We've gathered analysts' opinions on Immutep Ltd. future price: according to them, PRRUF price has a max estimate of 1.20 USD and a min estimate of 0.53 USD. Watch PRRUF chart and read a more detailed Immutep Ltd. stock forecast: see what analysts think of Immutep Ltd. and suggest that you do with its stocks.
PRRUF reached its all-time high on Dec 10, 2020 with the price of 0.8000 USD, and its all-time low was 0.0030 USD and was reached on Jul 31, 2008. View more price dynamics on PRRUF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PRRUF stock is 44.24% volatile and has beta coefficient of 0.94. Track Immutep Ltd. stock price on the chart and check out the list of the most volatile stocks — is Immutep Ltd. there?
Today Immutep Ltd. has the market capitalization of 247.67 M, it has increased by 4.77% over the last week.
Yes, you can track Immutep Ltd. financials in yearly and quarterly reports right on TradingView.
Immutep Ltd. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
PRRUF earnings for the last half-year are −0.01 USD per share, whereas the estimation was −0.01 USD, resulting in a 10.50% surprise. The estimated earnings for the next half-year are −0.01 USD per share. See more details about Immutep Ltd. earnings.
Immutep Ltd. revenue for the last half-year amounts to 2.80 M USD, despite the estimated figure of 1.87 M USD. In the next half-year revenue is expected to reach 2.08 M USD.
PRRUF net income for the last half-year is −14.45 M USD, while the previous report showed −12.84 M USD of net income which accounts for −12.59% change. Track more Immutep Ltd. financial stats to get the full picture.
No, PRRUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRRUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Immutep Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Immutep Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Immutep Ltd. stock shows the sell signal. See more of Immutep Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.